NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

FDA Delays Popular Nicotine Pouches Over Youth Risks

Popular nicotine pouches like Zyn and Velo remain unapproved in the US despite FDA fast-track. Agency hesitates due to rising youth use and addiction concerns.

FDA Delays Popular Nicotine Pouches Over Youth Risks
Credit: Bing Guan/Bloomberg
Already have an account? Sign in.
Featured/ 04/01/2026 · 12:16 PM
PM
/ Don’t stop at just one post.

Related↓

Zyn
Featured/ 10/21/2025 · 12:24 PM

Philip Morris Cuts Growth Forecast Despite Strong Zyn Performance

Philip Morris lowers 2025 operating income growth estimate to 10-11.5% due to heavy US investments in Zyn nicotine pouches, despite strong sales and raised earnings forecast.

/ Subscriber only
/ Read more

Feed↓

Nike Shakes Up Innovation Team Again as Stock Hits 10-Year Low
04/10/2026 · 3:52 PM

Nike Shakes Up Innovation Team Again as Stock Hits 10-Year Low

Nike innovation chief leaves after less than a year amid falling sales, China struggles, and faster rivals; company reshuffles leadership.

/ Subscriber only
Commvault Explores Sale After Takeover Interest from Thoma Bravo
04/10/2026 · 1:23 PM

Commvault Explores Sale After Takeover Interest from Thoma Bravo

Commvault may be sold as buyers show interest. Stock down on AI fears but revenue growing; Thoma Bravo among potential bidders.

/ Subscriber only
FDA Rejects Replimune’s Skin Cancer Drug for the Second Time
Featured/ 04/10/2026 · 12:06 PM

FDA Rejects Replimune’s Skin Cancer Drug for the Second Time

FDA again rejects Replimune’s skin cancer drug RP1, saying studies don’t prove it works; shares halted, setback for company.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe